Bio Pharmaceuticals Market
Bio Pharmaceuticals Market - Global Industry Assessment & Forecast
#
Pages:
141
Base Year:
2022
Mar - 2022
Format:
Report Code:
VMR-1415
Segments Covered
By
Type Monoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone, Others
-
By
Application Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, Other Applications
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 326.01 Billion |
 Revenue 2030:
|
USD 668.92 Billion |
 Revenue CAGR
(2023 - 2030): |
9.40% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Bio Pharmaceuticals Market Segment Analysis
- Bio Pharmaceuticals Type Outlook (Revenue, USD Million, 2018 - 2030)
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- Bio Pharmaceuticals Application Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
-
North America Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- U.S.
- U.S. Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- U.S. Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- U.S. Bio Pharmaceuticals Market, by Type
- Canada
- Canada Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- Canada Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- Canada Bio Pharmaceuticals Market, by Type
-
Mexico
- Mexico Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- Mexico Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- Mexico Bio Pharmaceuticals Market, by Type
-
North America Bio Pharmaceuticals Market, by Type
- Europe
-
Europe Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
-
Europe Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- U. K.
- U.K. Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- U.K. Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- U.K. Bio Pharmaceuticals Market, by Type
- France
- France Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- France Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- France Bio Pharmaceuticals Market, by Type
-
Germany
- Germany Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- Germany Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- Germany Bio Pharmaceuticals Market, by Type
-
Italy
- Italy Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- Italy Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- Italy Bio Pharmaceuticals Market, by Type
-
Spain
- Spain Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- Spain Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- Spain Bio Pharmaceuticals Market, by Type
-
Rest of Europe
- Rest of Europe Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- Rest of Europe Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- Rest of Europe Bio Pharmaceuticals Market, by Type
-
Europe Bio Pharmaceuticals Market, by Type
- Asia Pacific
-
Asia Pacific Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
-
Asia Pacific Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- China
- China Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- China Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- China Bio Pharmaceuticals Market, by Type
- Japan
- Japan Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- Japan Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- Japan Bio Pharmaceuticals Market, by Type
-
Germany
- Germany Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- Germany Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- Germany Bio Pharmaceuticals Market, by Type
-
India
- India Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- India Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- India Bio Pharmaceuticals Market, by Type
-
South Korea
- South Korea Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- South Korea Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- South Korea Bio Pharmaceuticals Market, by Type
-
South East Asia
- South East Asia Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- South East Asia Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- South East Asia Bio Pharmaceuticals Market, by Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- Rest of Asia Pacific Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- Rest of Asia Pacific Bio Pharmaceuticals Market, by Type
-
Asia Pacific Bio Pharmaceuticals Market, by Type
- Latin America
-
Latin America Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
-
Latin America Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- Brazil
- Brazil Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- Brazil Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- Brazil Bio Pharmaceuticals Market, by Type
- Argentina
- Argentina Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- Argentina Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- Argentina Bio Pharmaceuticals Market, by Type
-
Rest of Latin America
- Rest of Latin America Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- Rest of Latin America Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- Rest of Latin America Bio Pharmaceuticals Market, by Type
-
Latin America Bio Pharmaceuticals Market, by Type
- Middle East & Africa
-
Middle East & Africa Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
-
Middle East & Africa Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- GCC Countries
- GCC Countries Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- GCC Countries Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- GCC Countries Bio Pharmaceuticals Market, by Type
- South Africa
- South Africa Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- South Africa Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- South Africa Bio Pharmaceuticals Market, by Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Bio Pharmaceuticals Market, by Type
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- Rest of Middle East & Africa Bio Pharmaceuticals Market, by Application
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- Rest of Middle East & Africa Bio Pharmaceuticals Market, by Type
-
Middle East & Africa Bio Pharmaceuticals Market, by Type
- North America
FAQ
Frequently Asked Question
What is the global demand for Bio Pharmaceuticals in terms of revenue?
-
The global Bio Pharmaceuticals valued at USD 326.01 Billion in 2022 and is expected to reach USD 668.92 Billion in 2030 growing at a CAGR of 9.40%.
Which are the prominent players in the market?
-
The prominent players in the market are Abbott Laboratories Amgen Inc., Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., Novo Nordisk A/S Pfizer Inc., and Sanofi..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 9.40% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Bio Pharmaceuticals include
- Increasing Acceptance and Huge Market Demand for Biopharmaceuticals
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Bio Pharmaceuticals in 2022.
